Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Gastric and Gastroesophageal Junction Adenocarcinoma × trifluridine tipiracil drug combination × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Colorectal Cancer Metastatic 3 Advanced Solid Tumors 3 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Gastric and Gastroesophageal Junction Adenocarcinoma 1 ESCC 1 Anal Cancer Metastatic 1 Advanced/Metastatic Solid Tumors 1

Interventions

trifluridine tipiracil drug combination 1 tipiracil 1 pembrolizumab 1 Trifluridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05508737 2025-07-11

Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer

Yonsei University

Phase 1/2 Active not recruiting

Gastrointestinal

Gastric and Gastroesophageal Junction Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡